Center for Hearing and Deafness, University at Buffalo, 137 Cary Hall, Buffalo, NY 14221, USA.
Center for Hearing and Deafness, University at Buffalo, 137 Cary Hall, Buffalo, NY 14221, USA.
Hear Res. 2021 Feb;400:108125. doi: 10.1016/j.heares.2020.108125. Epub 2020 Nov 27.
Because cyclodextrins are capable of removing cholesterol from cell membranes, there is growing interest in using these compounds to treat diseases linked to aberrant cholesterol metabolism. One compound, 2-hydroxypropyl-beta-cyclodextrin (HPβCD), is currently being evaluated as a treatment for Niemann-Pick Type C1 disease, a rare, fatal neurodegenerative disease caused by the buildup of lipids in endosomes and lysosomes. HPβCD can reduce some debilitating symptoms and extend life span, but the therapeutic doses used to treat the disease cause hearing loss. Initial studies in rodents suggested that HPβCD selectively damaged only cochlear outer hair cells during the first week post-treatment. However, our recent in vivo and in vitro studies suggested that the damage could become progressively worse and more extensive over time. To test this hypothesis, we treated rats subcutaneously with 1, 2, 3 or 4 g/kg of HPβCD and waited for 8-weeks to assess the long-term histological consequences. Our new results indicate that the two highest doses of HPβCD caused extensive damage not only to OHC, but also to inner hair cells, pillar cells and other support cells resulting in the collapse and flattening of the sensory epithelium. The 4 g/kg dose destroyed all the outer hair cells and three-fourths of the inner hair cells over the basal two-thirds of the cochlea and more than 85% of the nerve fibers in the habenula perforata and more than 80% of spiral ganglion neurons in the middle of basal turn of the cochlea. The mechanisms that lead to the delayed degeneration of inner hair cells, pillar cells, nerve fibers and spiral ganglion neurons remain poorly understood, but may be related to the loss of trophic support caused by the degeneration of sensory and/or support cells in the organ of Corti. Despite the massive damage to the cochlear sensory epithelium, the blood vessels in the stria vascularis and the vestibular hair cells in the utricle and saccule remained normal.
由于环糊精能够从细胞膜中去除胆固醇,因此人们越来越感兴趣地将这些化合物用于治疗与异常胆固醇代谢有关的疾病。一种名为 2-羟丙基-β-环糊精(HPβCD)的化合物目前正在评估用于治疗尼曼-匹克 C1 型疾病,这是一种罕见的致命神经退行性疾病,由内体和溶酶体中脂质的积累引起。HPβCD 可以减轻一些使人衰弱的症状并延长寿命,但用于治疗该疾病的治疗剂量会导致听力损失。在啮齿动物中的初步研究表明,在治疗后第一周,HPβCD 仅选择性地损害耳蜗外毛细胞。然而,我们最近的体内和体外研究表明,随着时间的推移,损伤可能会变得越来越严重和广泛。为了验证这一假设,我们给大鼠皮下注射 1、2、3 或 4 g/kg 的 HPβCD,并等待 8 周以评估长期的组织学后果。我们的新结果表明,两种最高剂量的 HPβCD 不仅对 OHC 造成广泛损伤,还对内毛细胞、支柱细胞和其他支持细胞造成损伤,导致感觉上皮的塌陷和平坦化。4 g/kg 剂量破坏了耳蜗基底 2/3 处外毛细胞和内毛细胞的四分之三以上,以及 habenula perforata 中的神经纤维的 85%以上和耳蜗基底中部螺旋神经节神经元的 80%以上。导致内毛细胞、支柱细胞、神经纤维和螺旋神经节神经元延迟变性的机制尚不清楚,但可能与感觉和/或支持细胞变性引起的营养支持丧失有关。尽管耳蜗感觉上皮受到严重损伤,但血管纹中的血管和椭圆囊和球囊中的前庭毛细胞仍然正常。